| Antiretroviral Preexposure Prophylaxis for HIV Prevention. | |
| | |
MedLine Citation:
|
PMID: 23281987 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
To the Editor: Thigpen et al. (Aug. 2 issue)(1) report that persons who are seronegative for the human immunodeficiency virus (HIV) and who are receiving tenofovir disoproxil fumarate and emtricitabine (TDF-FTC) for preexposure prophylaxis had decreased bone mineral density at 24 months, as compared with those receiving placebo. In HIV-infected cohorts, TDF causes an initial loss of bone density over a period of 6 to 12 months, but there is stable bone density subsequently.(2),(3) These findings are consistent with other studies that have shown short-term loss of bone density in patients initiating antiretroviral treatment but stable bone density in . . . |
| | |
Authors:
|
Chris Kenyon; Robert Colebunders |
Related Documents
:
|
1082447 - A case of unusual sle related syndrome characterized by erythema multiforme, angioneuro... 7757107 - Disease distribution of beta 2-glycoprotein i-dependent anticardiolipin antibodies in r... 1540037 - A long-term immunological study of childhood onset systemic lupus erythematosus. 9918247 - Longitudinal determination of antiphospholipid antibodies in lupus patients without pre... 8683957 - Diagnosis and clinical course of canine oral papillomavirus infection. 17664817 - Significance of hbv dna by pcr over serological markers of hbv in acute and chronic pat... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The New England journal of medicine Volume: 368 ISSN: 1533-4406 ISO Abbreviation: N. Engl. J. Med. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-01-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0255562 Medline TA: N Engl J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 82-4 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antiretroviral Preexposure Prophylaxis for HIV Prevention.
Next Document: C-reactive protein, fibrinogen, and cardiovascular risk.